Group 1 - The core viewpoint of the news is that Bio Co., Ltd. has experienced a decline in stock price, with a cumulative drop of 5.58% over three consecutive days, closing at 8.12 yuan per share on September 4, with a total market value of 9.027 billion yuan [1] - Bio Co., Ltd. is primarily engaged in the research, production, and sales of veterinary biological products, with its main business revenue composition being 94.42% from biopharmaceuticals, 3.18% from other income, and 2.40% from supplementary sources [1] - The company has a trading volume of 1.93 billion yuan and a turnover rate of 2.12% on the reporting date [1] Group 2 - Huabao Fund has a significant holding in Bio Co., Ltd., with its Huabao CSI Agricultural, Animal Husbandry, and Fishery Index Initiation A Fund (013471) holding 191,300 shares, accounting for 1.79% of the fund's net value, ranking as the ninth largest holding [2] - The fund has incurred a floating loss of approximately 9,565 yuan today, with a total floating loss of 91,800 yuan during the three-day decline [2] - The fund was established on December 6, 2021, with a current scale of 29.4938 million yuan, and has achieved a year-to-date return of 11.39% [2]
生物股份股价连续3天下跌累计跌幅5.58%,华宝基金旗下1只基金持19.13万股,浮亏损失9.18万元